Institut de Biologie Structurale J-P Ebel (CEA-CNRS), 41 rue Jules Horowitz, 38027 Grenoble Cedex 1, France
* Author for correspondence (e-mail: margolis{at}ibs.fr )
Accepted 29 April 2002
![]() |
Summary |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Key words: S phase stasis, S phase, Mammalian, MCM proteins, Hydroxyurea, Aphidicolin
![]() |
Introduction |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
For licensing to occur, proteins important to the initiation of replication
are positioned at origins of replication in the nucleus during G1 under the
control of the origin recognition complex (ORC). Both Cdc6/18 and Cdt1 are
recruited to origins and in turn load the MCM proteins
(Blow and Tada, 2000;
Coleman et al., 1996
;
Donovan et al., 1997
;
Gillespie and Blow, 2000
;
Maiorano et al., 2000
;
Nishitani et al., 2000
;
Tanaka et al., 1997
). The MCM
proteins (MCM 2-7), a complex of related proteins
(Tye, 1999
) must be put in
place during G1 to initiate replication. They are then lost from the
chromatin-bound fraction as replication proceeds
(Aparicio et al., 1997
;
Hendrickson et al., 1996
;
Krude et al., 1996
;
Liang and Stillman, 1997
), and
must be replaced by Cdc6/18 and Cdt1-dependent processes in the following G1
for DNA replication to reinitiate.
The onset of S phase is triggered by the activity of the protein kinases
Cdc7-Dbf4, Cdk2-cyclin E and Cdk2-cyclin A
(Jiang et al., 1999a;
Johnston et al., 2000
;
Zou and Stillman, 1998
). These
protein kinases have two discrete functions, activating the replication
process and simultaneously eliminating Cdc6 activity by marking it for export
from the nucleus in higher eukaryotes
(Jiang et al., 1999a
;
Petersen et al., 1999
;
Saha et al., 1998
). The kinase
activity thus initiates S phase at the same time that it blocks reinitiation
of replication. By the onset of S phase, Cdt1 is largely gone
(Nishitani et al., 2001
).
Further, geminin, a recently described protein is produced during S phase
(McGarry and Kirschner, 1998
),
and suppresses residual Cdt1 (Nishitani et
al., 2001
; Tada et al.,
2001
; Wohlschlegel et al.,
2000
). As a result, for replication, the cell is dependent on MCM
that has been loaded at origins during G1, consistent with the licensing
function of the MCMs that permits only a single round of replication. If MCMs
were lost from an origin prior to replication, the associated origin should,
in principle, be unable to initiate replication. Cdc6 and Cdt1 are thus
limiting factors whose controlled loss from the nucleus during S phase
prevents reinitiation of replication until the next cell cycle at origins that
have already fired.
During S phase, replication can cease in response to DNA damage or stress
to the replication process. Stress can be induced by hydroxyurea or by
aphidicolin, two drugs with different mechanisms of action
(Ikegami et al., 1978;
Timson, 1975
) that suppress
migration of the replication fork without provoking DNA damage. Stress to the
replication process induces arrest through mechanisms different from those
invoked by DNA damage. DNA damage induces ATM protein kinase as a critical
intermediate blocking S phase progression, but stress does not
(Gottifredi et al., 2001
).
DNA-damage-induced arrest initiates a p53 and p21WAF1 response
(Dulic et al., 1994
;
el-Deiry et al., 1993
), with
p21WAF1 specifically binding to and inhibiting PCNA, the auxiliary
factor for DNA polymerases
and
(Li et al., 1994
;
Waga et al., 1994
). In
contrast, response to replicative stress arrests all cells regardless of p53
status (Linke et al., 1996
)
and is not accompanied by p21WAF1 induction
(Gottifredi et al., 2001
).
Additionally, cell cycle progression following release from HU block occurs
regardless of the presence of p53
(Gottifredi et al., 2001
).
Normally, cells reinitiate S phase rapidly and synchronously following release from hydroxyurea (HU) or aphidicolin, and such drug treatments are routinely used to generate cell synchrony at the G1/S phase boundary. However, we have noted in our work that a portion of the cell population of a number of mammalian cells does not reinitiate replication following arrest for approximately one cell cycle, but remains arrested with 2N DNA content. Here, we have addressed the status of the arrested cells, and found that all cycling cells have the capacity to permanently arrest following release from HU or aphidicolin, and that they appear to be arrested in S phase. There is no indication that arrest is due to DNA damage. However, we find that the MCM proteins are partially displaced from the chromatin-bound fraction during prolonged arrest. This loss is not sufficient to prevent at least partial replication of in vitro isolated nuclei. Whereas intact cells cannot replicate following release from prolonged S phase block, nuclei isolated from arrested cells remain competent to initiate DNA replication in vitro after 60 hours of arrest. We conclude that initiation of replication is specifically suppressed following prolonged arrest, perhaps in response to partial displacement of MCM proteins, generating a stable static population.
In mammalian cells, quiescence typically occurs in the G1 phase of the cell
cycle. When a quiescent state stems from serum starvation, contact inhibition,
senescence or differentiation, it is typically accompanied by induction of
p53, p21WAF1 and/or p27
(Johnson et al., 1998;
Kato et al., 1994
;
Polyak et al., 1994
;
Reynisdottir et al., 1995
;
Stein et al., 1999
). The
prolonged cell cycle arrest in S phase that we report here is thus novel, as
it is independent of the cyclin-dependent kinase inhibitors p21WAF1
and p27 and appears to involve indefinite suppression of the S phase
replicatory mechanism. The simplest interpretation of these results is that
cells become trapped in a state we call S phase stasis by irretrievable loss
of MCM proteins from the nuclear matrix, and thus cannot go forward to
replicate nor return to G1.
![]() |
Materials and Methods |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
G0 synchronization was obtained by growing REF-52 cells to confluency and maintaining them in contact inhibition (determined by absence of mitotic cells) for at least 24 hours. Cells were then released from contact inhibition by replating in fresh medium at a dilution of 1:5.
To synchronize REF-52 cells at the G1/S boundary, contact inhibited cells were replated in fresh medium and 8 hours later were exposed to aphidicolin for 15 hours. Aphidicolin, hydroxyurea, nocodazole and caffeine were applied at 10 µM, 2 mM, 0.25 µg/ml and 2 mM respectively. Aphidicolin and nocodazole were prepared as stock solutions in DMSO at 10 mM and 1 mg/ml, respectively. Hydroxyurea and caffeine were prepared as 200 mM stock solutions in DMEM containing 10% fetal bovine serum.
Flow cytometric analysis
For flow cytometry, attached cells were collected by trypsinization, pooled
with non-attached cells, centrifuged and resuspended in PBS, then fixed by the
addition of methanol to 90% at -20°C. After 10 minutes fixation, cells
were pelleted, then resuspended and stored in PBS with 0.04% sodium azide. For
flow cytometry fixed cells were washed with PBS and resuspended in 4 mM sodium
citrate containing 30 U/ml RNase A, 0.1% Triton X-100, and 50 µg/ml
propidium iodide and incubated for 10 minutes at 37°C. Sodium chloride was
then added to 138 mM. Data were collected using a FACScan apparatus (Becton
Dickinson, San Jose, CA) and results were analyzed with Becton Dickinson Cell
Quest software. For each sample, 10,000 events were collected and aggregated
cells were gated out.
Protein extraction and Cdk2/Cdc2 protein kinase assay
REF-52 cells were collected by trypsinization, washed with cold PBS, and
cell lysates were prepared in lysis buffer: 50 mM Tris-HCl, pH 7.4, 250 mM
NaCl, 5 mM EGTA, 0.1% NP-40 containing 4 mM Pefabloc, 10 µg/ml aprotinin,
10 µg/ml leupeptin, 60 mM ß-glycerophosphate, 50 mM NaF, and 0.5 mM
sodium vanadate, as previously described
(Andreassen and Margolis,
1994).
For kinase assays, 50 µg of each extract was incubated with 25 µl of
protein A-Sepharose 4B beads for 30 minutes at 4°C to preclear proteins
that bind nonspecifically to the beads. 4.0 µl of rabbit anti-Cdk2
antiserum (kind gift of R. Fotedar, Institut de Biologie Structurale,
Grenoble, France) or rabbit anti-Cdc2 antiserum
(Andreassen and Margolis, 1994)
was added to the extract for 1 hour at 4°C, followed by addition of 50
µl of protein A-Sepharose beads, and incubation for 1 hour at 4°C. The
resulting immune complex was washed three times with lysis buffer. The pellet
was washed once, then resuspended, in 50 µl of kinase buffer (50 mM Tris,
pH 7.4, 10 mM MgCl2, 1 mM DTT, 0.1 mg/ml BSA) containing 1 µg
calf thymus histone H1 (Roche Diagnostics), 30 µM ATP, and 5 µCi of
[
-32P]ATP (Amersham). The H1 kinase assay was carried out
for 30 minutes at 37°C and was terminated by the addition of
polyacrylamide sample buffer. Samples were then resolved by SDS-PAGE on 12%
polyacrylamide gels (19:1 ratio of acrylamide to bis-acrylamide)
(Andreassen and Margolis,
1994
). Autoradiographs were prepared by exposure to Hyperfilm-MP
(Amersham).
Chromatin and nuclear matrix fractionation
The chromatin/nuclear matrix fractionation assay was performed essentially
as described (Jiang et al.,
1999b) with minor modifications. Cells were trypsinized and washed
with 1 ml ice-cold PBS and then lysed in 500 µl of 10 mM Hepes pH 7.5, 1 mM
MgCl2, 1 mM EGTA, 1 mM DTT, 100 mM NaCl, 300 mM sucrose, containing
4 mM Pefabloc, 10 µg/ml aprotinin, 10 µg/ml leupeptin, 6 mM
ß-glycerophosphate, 5 mM NaF and 0.5 mM sodium vanadate for 25 minutes.
After low speed centrifugation (1500 g, 5 minutes, 4°C)
the nuclei were extracted once more with 250 µl of extraction buffer for 10
minutes, aliquoted and snap frozen in liquid nitrogen. The supernatants of the
first spins were respun at 16,000 g for 5 minutes and the
soluble fractions were aliquoted and snap frozen.
Immunoblotting
To prepare immunoblots, 20-30 µg of total protein were resolved on
polyacrylamide gels and proteins were transferred to nitrocellulose sheets
using semi-dry blotting apparatus. After blocking with 5% nonfat milk in TNT
buffer (25 mM Tris, pH 7.5, 150 mM sodium chloride, and 0.05% Tween 20)
nitrocellulose membranes were incubated overnight with primary antibodies in
TNT containing 5% nonfat milk. Nitrocellulose membranes were then washed, and
incubated for 1 hour with horseradish peroxidase-conjugated goat anti-rabbit
IgG secondary antibodies diluted in TNT with 5% nonfat milk. Development of
the protein-antibody complex was performed using enhanced chemiluminescence
according to manufacturer's instructions (Pierce, Rockford, IL).
Preparation of nuclei
Nuclei were prepared essentially as described
(Krude et al., 1997). Cells
from four 15 cm plates were trypsinised, pooled and washed once with ice cold
PBS and once with ice-cold hypotonic buffer. Pelleted nuclei (400 g,
4 minutes, 4°C, Eppendrof centrifuge) were resuspended in 1 ml of
hypotonic buffer (20 mM K-Hepes pH 7.8, 5 mM potassium acetate, 0.5 mM
MgCl2, 0.5 mM DTT), left on ice for 10 minutes and then disrupted
with 30 strokes in a Dounce homogenizer using a loose fitting pestle. After
centrifugation (1500 g, 5 minutes, 4°C), pelleted nuclei were
washed three times with PBS and resuspended in 0.1 ml of PBS containing 5%
DMSO, aliquoted and snap frozen in liquid nitrogen.
In vitro DNA synthesis reaction
In vitro DNA synthesis was performed on isolated nuclei as described
(Krude et al., 1997). 20 µl
of nuclei were incubated in a final volume of 50 µl for each sample in 40
mM K-Hepes pH 7.8, 7 mM MgCl2, 3 mM ATP, 0.1 mM each of GTP, CTP,
UTP, dATP, dGTP and dCTP, 0.25 µM biotin-16dUTP, 0.5 mM DTT, 40 mM creatine
phosphate and 5 µg of phosphocreatine kinase for 2 hours at 37°C.
Reactions were stopped by diluting with 450 µl of PBS and nuclei were fixed
by adding 500 µl of 8% paraformaldehyde. After 5 minutes at room
temperature, nuclei were pelleted (8 minutes, 2000 g, Eppendorf
centrifuge). The nuclei were then resuspended in 100 µl of 30% sucrose in
PBS and spun onto poly-lysine-coated coverslips.
Immunofluorescence microscopy
For in vivo determination of DNA replication, cells were pulsed for 30
minutes with 10 µM bromodeoxyuridine (BrdU) prior to being harvested. For
BrdU labelling, cells were grown on poly-lysine-coated glass coverslips and
then fixed for 20 minutes at 37°C with 2% paraformaldehyde in PBS, washed
with PBS, permeabilized with 0.2% Triton X-100 in PBS for 3 minutes, and
washed again with PBS. Coverslips were then incubated for 30 minutes in 2N
HCl/0.5% Triton X-100, washed with PBS and neutralysed with 0.1 M sodium
tetraborate, pH 8.5, for 5 minutes. After washing with PBS, cells were
incubated with FITC-conjugated anti-BrdU (Becton Dickinson, San Jose, CA)
diluted 30-fold in PBS/0.5% Tween 20/1% bovine serum albumin. In all cases,
cells were counterstained with propidium iodide (25 µg/ml) containing RNase
A (1 µg/ml).
For observation of in vitro replication, isolated nuclei were labeled with FITC-conjugated streptavidin (Vector Laboratories, Burlingame, CA), diluted 50-fold in PBS/0.5% Tween 20/1% bovine serum albumin, to detect incorporation of biotin-16-dUTP. Nuclei were counterstained with propidium iodide (25 µg/ml) containing Rnase A (1 µg/ml).
For microscopy, coverslips were mounted as previously described
(Andreassen et al., 1991) and
observed using an MRC-600 Laser Scanning confocal apparatus (Bio-Rad
Microscience Division, Hemel Hempstead, UK).
![]() |
Results |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
REF-52 cells were blocked at the G1/S transition by exposure to either 10 µM aphidicolin or 2 mM HU for different times, as indicated (Fig. 1), then released into nocodazole for 24 hours. Cells that were capable of progressing from the S phase block to mitosis would then collect as a 4N population. The result that we obtained was striking. After as little as 24 hours exposure to either drug, at least 50% of the randomly cycling population was unable to recover and progress in the cell cycle (Fig. 1A). HU appeared to cause a more rapid progression to arrest, as the majority of HU exposed cells could not recover after 24 hours exposure. However, despite the different mechanisms of action of the two drugs, the outcome with respect to entry into arrest was the same.
|
Many cell cycle checkpoint controls involve either p53 or pRB, but the
progression of cells to stasis was independent of p53 or pRB controls, and
thus not equivalent to entry into G1 quiescence. SV40 large T-antigen
suppresses the checkpoint functions of both p53 and pRB
(Ludlow et al., 1989;
Zhu et al., 1991
). TAG cells
are a REF-52-derived cell line transformed by large T-antigen. When we
performed a parallel analysis on TAG cells, exposing cells to either HU or
aphidicolin in the presence of nocodazole, we found essentially the same
capacity to permanently arrest as the REF-52 parental line after 30 hours
exposure to either HU or aphidicolin (Fig.
2). We note that at the earliest time of exposure (15 hours), a
substantial number of TAG cells progress past 4N or are less than 2N and
clearly dying. This effect results from the failure of TAG cells to arrest in
tetraploid G1 following nocodazole exposure
(Andreassen et al., 2001
).
These cells rapidly progress towards aneuploidy and apoptosis. The observed
aneuploidy and death are independent of S phase arrest, as longer times of
exposure actually protect cells against these outcomes by maintaining S phase
blocked and released cells in 2N arrest.
|
REF-52 cells were also released from G0 block and exposed to either HU or aphidicolin for varying times before release into nocodazole. The cells arrested, but this effect occurred after a longer time of exposure to drug than was observed in randomly cycling cells, presumably because of the longer time required for cells to reach the G1/S boundary from G0 than from the random cycle. Arrest was typically nearly complete after 45 hours of exposure to either drug (Fig. 3). Further, the observed arrest persisted over a period of 7 days following release from aphidicolin S phase block (Fig. 4A), and failure of cell cycle progression correlated with results of proliferation curves following release from aphidicolin over a period of 2 days (Fig. 4B).
|
|
The entry into arrest was not unique to rat REF-52 and TAG cells. Parallel results were obtained with primary human fibroblast (IMR-90) cells that were either randomly cycling (Fig. 5) or synchronized in G0 (data not shown) prior to drug treatment, and arrest in these cells also followed exposure to either HU or aphidicolin.
|
Permanently arrested cells maintain continuing S phase status
We wanted to understand the nature of the blocked state that these cells
exhibited after prolonged exposure to S phase arrest. Typically, when
mammalian cells enter into a quiescent state, it is in G1 phase. Exit from the
cell cycle may be either temporary, such as during serum starvation or contact
inhibition, or permanent, as typified by senescence. We therefore asked
whether these cells reverted to a G1 or G0 state in prolonged arrest, or if
they remained in S phase but lost the capacity to replicate.
In order to determine the cell cycle status of the arrested cells, we
exposed REF-52 cells, released from contact inhibition, to aphidicolin for 15,
30, 45 or 60 hours, then prepared cell extracts to assay for the abundance of
different cell cycle markers. All the markers that we assayed were consistent
with a continuing S phase status in the prolonged arrest
(Fig. 6A). PCNA, a DNA
polymerase cofactor required for S phase progression, was equally abundant at
30, 45 and 60 hours. Other proteins required for S phase progression, such as
cyclin A and Cdk2, also were not diminished. In contrast, proteins required
for G1 progression (Cdk4) or S phase entry (cyclin E) had diminished at later
time points of arrest. The cyclin-dependent kinase inhibitors of G1
progression, p27 and p21, were diminished or nearly absent in the arrested
state. The relative absence of p21, which is transactivated by p53 and can
provoke S phase arrest in response to DNA damage
(Li et al., 1994;
Waga et al., 1994
), is
consistent with the parallel induction of arrest independent of the p53 status
of the treated cells. We conclude from this evidence that the cells remain in
S phase and do not revert to G1 or G0 status when they arrest.
|
Cdk2, the cyclin-dependent kinase required for S phase progression
(Tsai et al., 1993), showed
activity levels consistent with continuing S phase status of the arrested
cells (Fig. 6B). Interestingly,
Cdc2, the cyclin-dependent kinase required for G2/M progression
(Draetta and Beach, 1988
), was
more abundant at the 45 hours arrest point than at 30 hours
(Fig. 6A), and also showed
higher activity levels (Fig.
6B) at this time point. Despite the increase in Cdc2 activity,
there was no physical evidence for mitotic entry of the blocked cells. In
fact, despite the presence of Cdc2 activity, attempts to induce checkpoint
override from S phase with caffeine
(Schlegel and Pardee, 1986
)
did not induce mitotic entry in either 45 or 60 hours arrested cells (data not
shown).
Progression in S phase is accompanied by the continuous loss of the MCM
family of proteins from the chromatin-bound fraction
(Aparicio et al., 1997;
Hendrickson et al., 1996
;
Krude et al., 1996
;
Liang and Stillman, 1997
). The
MCM proteins are loaded onto chromatin by the G1-specific factors Cdc6/18 and
Cdt1 (Blow and Tada, 2000
;
Coleman et al., 1996
;
Donovan et al., 1997
;
Gillespie and Blow, 2000
;
Maiorano et al., 2000
;
Nishitani et al., 2000
;
Tanaka et al., 1997
), are
absolutely required for replication, and are lost from chromatin in the late
cell cycle to prevent re-replication of the genome
(Tye, 1999
). We have followed
the status of two of the members of the MCM protein complex, MCM3 and MCM4,
during S phase blockage, and have consistently found a partial loss from the
chromatin-bound fraction during prolonged drug exposure
(Fig. 6A). MCM presence on
chromatin in S phase is partially controlled by an interplay with geminin
(Wohlschlegel et al., 2000
).
After Cdt1 helps load the MCM proteins on chromatin in G1, the increasing
abundance of geminin during S phase suppresses Cdt1 and permits MCM loss
(Nishitani et al., 2001
;
Wohlschlegel et al., 2000
).
The observed loss of MCM in replication block might be due to the persistence
of geminin if it continued to be translated during the S phase block. We
therefore tested for the relative levels of geminin in cells blocked in S
phase for varying amounts of time. Consistently, we found that geminin levels
persisted and even increased as the cells became permanently arrested
(Fig. 6C). We found that
geminin was largely in the chromatin unbound fraction
(Fig. 6C), indicating that
there was little change in geminin-binding status on chromatin as cells
entered arrest.
Do arrested cells retain S phase competence?
Our evidence indicates that cells that remain arrested following release
from prolonged exposure to S phase inhibitors remain in an S phase state. From
FACscan analysis, we do not observe the majority of the population progressing
from an apparent 2N status. There is, however, the possibility that a small
degree of replication can occur in these cells. To assay for a low level of
replication, we exposed cells to BrdU over a 5 hour period of time following
release from aphidicolin arrest. After release from contact inhibition, REF-52
cells were exposed to aphidicolin for various times, then assayed by
immunofluorescence for BrdU uptake following aphidicolin release
(Fig. 7A). By 15-20 hours after
release from contact inhibition, cells are not yet in S phase, and lack of
BrdU uptake in the population treated for 15 hours serves as a negative
control. By contrast, the 30 hours population is fully competent to recover
and proceed to mitosis, serving as a positive control for the sensitivity of
the assay. In the immunofluorescence assay, two-thirds of the population
competent to replicate was positive. In comparison with these values, cells
released after 45 hours in aphidicolin had a low but statistically significant
subpopulation capable of at least some replication. After 60 hours of
aphidicolin, there was no perceptible incorporation of BrdU. We conclude that
the majority of cells after 45 hours, and all of the cells after 60 hours of
aphidicolin treatment show no evidence of DNA replication.
|
We next asked whether the failure to replicate reflected the loss of
competence to initiate replication or whether a factor was present in nuclei
that actively interfered with initiation of replication, perhaps in response
to decreased levels of bound MCM protein. To address this issue, we isolated
nuclei from cells treated for varying periods of time with aphidicolin
following release from contact inhibition, then assayed their capacity to
replicate in an in vitro assay system (Fig.
7B,C) (Krude et al.,
1997) using a biotin-dUTP incorporation immunofluorescence assay
(Krude et al., 1997
). The
result was striking. Whereas nuclei treated for 15 hours, not yet in S phase,
did not replicate (Fig. 7B,C),
nuclei from cells treated with aphidicolin for 30 or 60 hours then released
showed sufficient replication to be positive by immunofluorescence assay. We
conclude that prolonged exposure to S phase arrest provokes an active and
durable suppression of S phase recovery, rather than total loss of replication
competence.
![]() |
Discussion |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
The arrested state, which we call S phase stasis, arises following
prolonged S phase inhibition with either HU or aphidicolin. The two drugs have
different mechanisms of action. HU blocks ribonucleoside diphosphate reductase
thus blocking production of the deoxyribonucleotide required for replication
(Timson, 1975), while
aphidicolin specifically inhibits nuclear DNA synthesis by suppressing DNA
polymerase
(Ikegami et al.,
1978
). Neither drug creates DNA damage, and both are readily
reversible following short-term exposure. The absence of DNA damage is in
accord with the absence of requirement for p53 or pRB to mediate S phase
arrest during drug exposure. Arrest in S phase requires active suppression
through transactivation of suppressors, direct binding of suppressors to
replication machinery, and phosphorylation of critical elements of replication
control (Kelly and Brown,
2000
). All of these inhibitory activities are reversible following
resolution of the stress that caused the replication arrest. S phase stasis is
unlikely to result from a permanent alteration of one of these transient
events.
Since we observe depletion of chromatin-bound MCM in arrested cells, it is
conceivable that S phase stasis arises in response to changes in MCM or in the
activity of the proteins that maintain them in chromatin-bound status.
Chromatin-associated MCM proteins are essential for replication, and are
displaced from chromatin as S phase progresses. As a consequence, G2 nuclei
are unable to replicate in an in vitro replication system unless MCM proteins
are restored to the chromatin-bound fraction by inhibition of protein kinase
activity (Coverley et al.,
2000). The MCM proteins, if lost from chromatin during S phase,
cannot be replaced, as they are put in place by G1 processes involving the
ORC, Cdc6/18 and Cdt1. The result of such loss during prolonged S phase arrest
would be a cell that cannot complete S phase. Our evidence reveals that MCM3
and MCM4, two markers of the complex, are indeed partially depleted from the
chromatin-bound fraction during prolonged S phase arrest.
Surprisingly, nuclei isolated from cells blocked for 60 hours in the
presence of aphidicolin are as capable of initiating replication without added
factors as are nuclei from S phase competent cells (30 hours arrest). In
contrast, G1 nuclei (15 hours after release from serum starvation) used as
controls in our experiments are incapable of incorporating biotin-dUTP. The
incapacity of G1 nuclei to replicate is in accord with previous results which
have shown that nuclei isolated from G1 cells do not have the capacity to
replicate DNA unless incubated with S phase nuclei or extracts of S phase
nuclei (Krude et al.,
1997).
Following partial loss of MCM complex from the chromatin in prolonged drug treatment (Fig. 6), it is unlikely that in vitro replication progresses much beyond initiation. This result is nonetheless strikingly distinct from loss of replication capacity in intact cells. The in vitro assay of biotin-dUTP incorporation should not be interpreted as indicating the capacity for full replication in vitro. Positive nuclei would be generated with even partial replication. It has not been possible to quantitate the degree of replication in individual nuclei, but it is unlikely that, with the partial loss of MCM, complete replication competence is retained.
Since nuclei isolated from permanently arrested S phase cells are capable of initiating replication in vitro, we conclude that the replication machinery remains at least partially competent but that there is active suppression of replication in the intact cell following release from prolonged S phase arrest, presumably through checkpoint controls that read the inability of MCM-depleted chromatin to complete S phase. If such a checkpoint signal exists, it is likely to be readily diffused from nuclei during their isolation or inactivated by in vitro conditions, so that it does not function to suppress in vitro replication.
We note that HeLa cells exhibit behavior unlike that observed with the
cells studied here. They undergo a partial replication on release from
prolonged S phase arrest, followed by rapid apoptotic death (data not shown).
HeLa are highly transformed and highly aneuploid. This result suggests that
the alternative to maintenance of cells at the G1/S interface following
partial loss of replicative capacity is rapid death following incomplete
replication. We intend to address the possibility that transformed cells
exhibiting chromosome instability may be uniquely sensitive to drugs that
suppress S phase without damaging DNA. As aneuploidy and chromosomal
instability (CIN) are characteristic of the great majority of human tumors
(Cahill et al., 1998;
Lengauer et al., 1997
), and
are linked to the progressive development of high-grade, invasive tumors
(Giaretti, 1994
;
Rabinovitch et al., 1989
;
Sandberg, 1977
), such a
linkage between CIN status and increased sensitivity to replication inhibitors
could be important.
The question arises whether S phase stasis occurs only in response to drug
exposure, or if it could occur in response to physiological stimuli. The
difference between our results in cells and in isolated nuclei suggests that a
diffusible factor can specifically suppress replication in the absence of DNA
damage in S phase. We therefore suggest that such a factor should have a role
in suppressing replication as a normal physiological response. Further work
will establish whether this is so. It is possible that the well-established
cell cycle checkpoint triggered in response to incomplete DNA replication
(Dasso and Newport, 1990)
involves checkpoint machinery similar or identical to that described here in
response to prolonged drug arrest. It is of interest that geminin, which we
find persists in S phase arrested nuclei
(Fig. 6), both suppresses
replication (Wohlschlegel et al.,
2000
) and depletes XMCM7 from the chromatin-bound fraction
(Tada et al., 2001
) in an in
vitro Xenopus extract system. It will be interesting to determine
whether similar S phase stasis will occur in response to prolonged incomplete
DNA replication created in the absence of drugs.
HU is used for treatment of myeloproliferative disorders such as essential
thrombocythaemia (Green,
1999), but the mechanism of action that permits HU to be an
effective treatment has not been clear. Our data suggest that transient
suppression of replication may be augmented in the sensitive megakaryocyte
cell population by permanent arrest of a portion of the cells exposed to HU.
It remains to be seen whether megakaryocytes are especially sensitive to entry
into stasis in the presence of HU. This possibility is interesting, as the S
phase of differentiating megakaryocytes is distinct. Megakaryocytes undergo
repeated endoreduplication without cell cleavage
(Jackson, 1990
), leading to
multinucleation and polyploidy prior to the generation of platelets from the
mature cell population. In this special case, the reloading of MCM proteins
may be under controls that are distinct from those described above for normal
cycling cells, and might thus be unusually sensitive to entry into S phase
stasis.
![]() |
Acknowledgments |
---|
![]() |
References |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Andreassen, P. R. and Margolis, R. L. (1994). Microtubule dependency of p34cdc2 inactivation and mitotic exit in mammalian cells. J. Cell Biol. 127,789 -802.[Abstract]
Andreassen, P. R., Palmer, D. K., Wener, M. H. and Margolis, R. L. (1991). Telophase disc: a new mammalian mitotic organelle that bisects telophase cells with a possible function in cytokinesis. J. Cell Sci. 99,523 -534.[Abstract]
Andreassen, P. R., Lohez, O. D., Lacroix, F. B. and Margolis, R.
L. (2001). Tetraploid state induces p53-dependent arrest of
nontransformed mammalian cells in G1. Mol. Biol. Cell
12,1315
-1328.
Aparicio, O. M., Weinstein, D. M. and Bell, S. P. (1997). Components and dynamics of DNA replication complexes in S. cerevisiae: redistribution of MCM proteins and Cdc45p during S phase. Cell 91,59 -69.[Medline]
Blow, J. J. and Tada, S. (2000). Cell cycle. A new check on issuing the licence. Nature 404,560 -561.[Medline]
Cahill, D. P., Lengauer, C., Yu, J., Riggins, G. J., Willson, J. K., Markowitz, S. D., Kinzler, K. W. and Vogelstein, B. (1998). Mutations of mitotic checkpoint genes in human cancers. Nature 392,300 -303.[Medline]
Coleman, T. R., Carpenter, P. B. and Dunphy, W. G. (1996). The Xenopus Cdc6 protein is essential for the initiation of a single round of DNA replication in cell-free extracts. Cell 87,53 -63.[Medline]
Coverley, D., Pelizon, C., Trewick, S. and Laskey, R. A.
(2000). Chromatinbound Cdc6 persists in S and G2 phases in human
cells, while soluble Cdc6 is destroyed in a cyclin A-cdk2 dependent process.
J. Cell Sci. 113,1929
-1938.
Dasso, M. and Newport, J. W. (1990). Completion of DNA replication is monitored by a feedback system that controls the initiation of mitosis in vitro: studies in Xenopus. Cell 61,811 -823.[Medline]
Donovan, S., Harwood, J., Drury, L. S. and Diffley, J. F.
(1997). Cdc6p-dependent loading of Mcm proteins onto
pre-replicative chromatin in budding yeast. Proc. Natl. Acad. Sci.
USA 94,5611
-5616.
Draetta, G. and Beach, D. (1988). Activation of cdc2 protein kinase during mitosis in human cells: cell cycle-dependent phosphorylation and subunit rearrangement. Cell 54, 17-26.[Medline]
Dulic, V., Kaufmann, W. K., Wilson, S. J., Tlsty, T. D., Lees, E., Harper, J. W., Elledge, S. J. and Reed, S. I. (1994). p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell 76,1013 -1023.[Medline]
el-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W. and Vogelstein, B. (1993). WAF1, a potential mediator of p53 tumor suppression. Cell 75,817 -825.[Medline]
Giaretti, W. (1994). A model of DNA aneuploidization and evolution in colorectal cancer. Lab. Invest. 71,904 -910.[Medline]
Gillespie, P. J. and Blow, J. J. (2000).
Nucleoplasmin-mediated chromatin remodelling is required for Xenopus sperm
nuclei to become licensed for DNA replication. Nucleic Acids
Res. 28,472
-480.
Gottifredi, V., Shieh, S., Taya, Y. and Prives, C.
(2001). p53 accumulates but is functionally impaired when DNA
synthesis is blocked. Proc. Natl. Acad. Sci. USA
98,1036
-1041.
Green, A. R. (1999). The pathogenesis and management of essential thrombocythaemia. Haematologica 84,36 -39.[Medline]
Hendrickson, M., Madine, M., Dalton, S. and Gautier, J.
(1996). Phosphorylation of MCM4 by cdc2 protein kinase inhibits
the activity of the minichromosome maintenance complex. Proc. Natl.
Acad. Sci. USA 93,12223
-12228.
Ikegami, S., Taguchi, T., Ohashi, M., Oguro, M., Nagano, H. and Mano, Y. (1978). Aphidicolin prevents mitotic cell division by interfering with the activity of DNA polymerase-alpha. Nature 275,458 -460.[Medline]
Jackson, C. W. (1990). Megakaryocyte endomitosis: a review. Int. J. Cell Cloning 8, 224-226.[Abstract]
Jiang, W., McDonald, D., Hope, T. J. and Hunter, T.
(1999a). Mammalian Cdc7-Dbf4 protein kinase complex is essential
for initiation of DNA replication. EMBO J.
18,5703
-5713.
Jiang, W., Wells, N. J. and Hunter, T. (1999b).
Multistep regulation of DNA replication by Cdk phosphorylation of HsCdc6.
Proc. Natl. Acad. Sci. USA
96,6193
-6198.
Johnson, D., Frame, M. C. and Wyke, J. A. (1998). Expression of the v-Src oncoprotein in fibroblasts disrupts normal regulation of the CDK inhibitor p27 and inhibits quiescence. Oncogene 16,2017 -2028.[Medline]
Johnston, L. H., Masai, H. and Sugino, A. (2000). A Cdc7p-Dbf4p protein kinase activity is conserved from yeast to humans. Prog. Cell Cycle Res. 4, 61-69.[Medline]
Kato, J. Y., Matsuoka, M., Polyak, K., Massague, J. and Sherr, C. J. (1994). Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27Kip1) of cyclin-dependent kinase 4 activation. Cell 79,487 -496.[Medline]
Kelly, T. J. and Brown, G. W. (2000). Regulation of chromosome replication. Annu. Rev. Biochem. 69,829 -880.[Medline]
Krude, T., Musahl, C., Laskey, R. A. and Knippers, R.
(1996). Human replication proteins hCdc21, hCdc46 and P1Mcm3 bind
chromatin uniformly before S-phase and are displaced locally during DNA
replication. J. Cell. Sci.
109,309
-318.
Krude, T., Jackman, M., Pines, J. and Laskey, R. A. (1997). Cyclin/Cdk-dependent initiation of DNA replication in a human cell-free system. Cell 88,109 -119.[Medline]
Lengauer, C., Kinzler, K. W. and Vogelstein, B. (1997). Genetic instability in colorectal cancers. Nature 386,623 -627.[Medline]
Li, R., Waga, S., Hannon, G. J., Beach, D. and Stillman, B. (1994). Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair. Nature 371,534 -537.[Medline]
Liang, C. and Stillman, B. (1997). Persistent
initiation of DNA replication and chromatin-bound MCM proteins during the cell
cycle in cdc6 mutants. Genes Dev.
11,3375
-3386.
Linke, S. P., Clarkin, K. C., di Leonardo, A., Tsou, A. and Wahl, G. M. (1996). A reversible, p53-dependent G0/G1 cell cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage. Genes Dev. 10,934 -947.[Abstract]
Ludlow, J. W., DeCaprio, J. A., Huang, C. M., Lee, W. H., Paucha, E. and Livingston, D. M. (1989). SV40 large T antigen binds preferentially to an underphosphorylated member of the retinoblastoma susceptibility gene product family. Cell 56, 57-65.[Medline]
Maiorano, D., Moreau, J. and Mechali, M. (2000). XCDT1 is required for the assembly of pre-replicative complexes in Xenopus laevis. Nature 404,622 -625.[Medline]
McGarry, T. J. and Kirschner, M. W. (1998). Geminin, an inhibitor of DNA replication, is degraded during mitosis. Cell 93,1043 -1053.[Medline]
Nishitani, H., Lygerou, Z., Nishimoto, T. and Nurse, P. (2000). The Cdt1 protein is required to license DNA for replication in fission yeast. Nature 404,625 -628.[Medline]
Nishitani, H., Taraviras, S., Lygerou, Z. and Nishimoto, T.
(2001). The human licensing factor for DNA replication Cdt1
accumulates in G1 and is destabilized after initiation of S-phase.
J. Biol. Chem. 276,44905
-44911.
Pardee, A. B. (1989). G1 events and regulation of cell proliferation. Science 246,603 -608.[Medline]
Perry, M. E., Commane, M. and Stark, G. R. (1992). Simian virus 40 large tumor antigen alone or two cooperating oncogenes convert REF52 cells to a state permissive for gene amplification. Proc. Natl. Acad. Sci. USA 89,8112 -8116.[Abstract]
Petersen, B. O., Lukas, J., Sorensen, C. S., Bartek, J. and
Helin, K. (1999). Phosphorylation of mammalian CDC6 by cyclin
A/CDK2 regulates its subcellular localization. EMBO J.
18,396
-410.
Polyak, K., Lee, M. H., Erdjument-Bromage, H., Koff, A., Roberts, J. M., Tempst, P. and Massague, J. (1994). Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78, 59-66.[Medline]
Rabinovitch, P. S., Reid, B. J., Haggitt, R. C., Norwood, T. H. and Rubin, C. E. (1989). Progression to cancer in Barrett's esophagus is associated with genomic instability. Lab Invest. 60,65 -71.[Medline]
Rao, P. N. and Johnson, R. T. (1970). Mammalian cell fusion: studies on the regulation of DNA synthesis and mitosis. Nature 225,159 -164.[Medline]
Reynisdottir, I., Polyak, K., Iavarone, A. and Massague, J. (1995). Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta. Genes Dev. 9,1831 -1845.[Abstract]
Saha, P., Chen, J., Thome, K. C., Lawlis, S. J., Hou, Z. H.,
Hendricks, M., Parvin, J. D. and Dutta, A. (1998). Human
CDC6/Cdc18 associates with Orc1 and cyclin-cdk and is selectively eliminated
from the nucleus at the onset of S phase. Mol. Cell.
Biol. 18,2758
-2767.
Sandberg, A. A. (1977). Chromosome markers and progression in bladder cancer. Cancer Res. 37,2950 -2956.[Medline]
Schlegel, R. and Pardee, A. B. (1986). Caffeine-induced uncoupling of mitosis from the completion of DNA replication in mammalian cells. Science 232,1264 -1266.[Medline]
Stein, G. H., Drullinger, L. F., Soulard, A. and Dulic, V.
(1999). Differential roles for cyclin-dependent kinase inhibitors
p21 and p16 in the mechanisms of senescence and differentiation in human
fibroblasts. Mol. Cell. Biol.
19,2109
-2117.
Tada, S., Li, A., Maiorano, D., Mechali, M. and Blow, J. J. (2001). Repression of origin assembly in metaphase depends on inhibition of RLF-B/Cdt1 by geminin. Nat. Cell Biol. 3, 107-113.[Medline]
Tanaka, T., Knapp, D. and Nasmyth, K. (1997). Loading of an Mcm protein onto DNA replication origins is regulated by Cdc6p and CDKs. Cell 90,649 -660.[Medline]
Timson, J. (1975). Hydroxyurea. Mutat. Res. 32,115 -132.[Medline]
Tsai, L. H., Lees, E., Faha, B., Harlow, E. and Riabowol, K. (1993). The cdk2 kinase is required for the G1-to-S transition in mammalian cells. Oncogene 8,1593 -1602.[Medline]
Tye, B. K. (1999). MCM proteins in DNA replication. Annu. Rev. Biochem. 68,649 -686.[Medline]
Waga, S., Hannon, G. J., Beach, D. and Stillman, B. (1994). The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 369,574 -578.[Medline]
Wohlschlegel, J. A., Dwyer, B. T., Dhar, S. K., Cvetic, C.,
Walter, J. C. and Dutta, A. (2000). Inhibition of eukaryotic
DNA replication by geminin binding to Cdt1. Science
290,2309
-2312.
Zhu, J. Y., Abate, M., Rice, P. W. and Cole, C. N. (1991). The ability of simian virus 40 large T antigen to immortalize primary mouse embryo fibroblasts cosegregates with its ability to bind to p53. J. Virol. 65,6872 -6880.[Medline]
Zou, L. and Stillman, B. (1998). Formation of a
preinitiation complex by S-phase cyclin CDK-dependent loading of Cdc45p onto
chromatin. Science 280,593
-596.